Waran Seri I ITSEC Asia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Waran Seri I ITSEC Asia Tbk. trades at Rp376 (market cap 154.89B, 900 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Waran Seri I ITSEC Asia Tbk. and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (62.5K versus 900). Which is the better fit depends on your goals.
| CYBR-W | OBAT | |
|---|---|---|
Market Cap | 154.89B | 164.65B |
Volume | 900 | 62.5K |
Lot | 9 | 625 |
Turnover | 337K | 15.03M |
Average Price | 374.44 | 240.55 |
Value | 337K | 15.03M |
Indicative Equilibrium Price | — | 238 |
Indicative Equilibrium Volume | — | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT ITSEC Asia Tbk (the “Company”) was established based on Notarial Deed No. 7 dated April 12, 2010 of Refizal, S.H., M.Hum., notary in Jakarta. The Company started its commercial operations in 2010.
Read more on CYBR-W →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →